ZYBT

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Index	-	P/E	279.88	EPS (ttm)	0.03	Insider Own	90.66%	Shs Outstand	47.17M	Perf Week	13.80%
Market Cap	441.67M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	4.43M	Perf Month	10.95%
Enterprise Value	460.16M	PEG	-	EPS next Q	-	Inst Own	0.89%	Short Float	4.49%	Perf Quarter	27.85%
Income	1.57M	P/S	17.06	EPS this Y	-	Inst Trans	0.41%	Short Ratio	1.03	Perf Half Y	109.91%
Sales	25.89M	P/B	11.30	EPS next Y	-	ROA	2.27%	Short Interest	0.20M	Perf YTD	91.77%
Book/sh	0.82	P/C	160.61	EPS next 5Y	-	ROE	4.06%	52W High	14.30 -34.83%	Perf Year	-
Cash/sh	0.06	P/FCF	115.32	EPS past 3/5Y	-36.18% -	ROIC	3.97%	52W Low	3.50 166.29%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	82.17	Sales past 3/5Y	-7.94% -	Gross Margin	48.96%	Volatility	19.37% 24.23%	Perf 5Y	-
Dividend TTM	-	EV/Sales	17.77	EPS Y/Y TTM	-64.87%	Oper. Margin	8.80%	ATR (14)	1.68	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	0.80	Sales Y/Y TTM	-13.57%	Profit Margin	6.06%	RSI (14)	54.13	Recom	-
Dividend Gr. 3/5Y	- -	Current Ratio	1.31	EPS Q/Q	-79.39%	SMA20	6.57%	Beta	-	Target Price	-
Payout	-	Debt/Eq	0.30	Sales Q/Q	-2.78%	SMA50	32.33%	Rel Volume	1.47	Prev Close	9.21
Employees	277	LT Debt/Eq	0.02	Earnings	-	SMA200	42.14%	Avg Volume	192.22K	Price	9.32
IPO	Jan 07, 2025	Option/Short	No / No	EPS/Sales Surpr.	- -	Trades		Volume	290,766	Change	1.19%

Jul-03-25 08:30AM	Zhengye Biotechnology Holding Limited Announces Fiscal Year 2024 Financial Results (PR Newswire)
May-23-25 04:05PM	Zhengye Biotechnology Holding Limited Receives NASDAQ Notice Related to Late Filing of Form 20-F (GlobeNewswire) -12.33%
Jan-14-25 12:00PM	Zhengye Biotechnology Holding Limited Announces Full Exercise of Underwriters' Over-Allotment Option (GlobeNewswire)
Jan-08-25 12:00PM	Zhengye Biotechnology Holding Limited Announces Closing of Initial Public Offering (GlobeNewswire) -7.41%
Jan-06-25 05:50PM	Zhengye Biotechnology Holding Limited Announces Pricing of Initial Public Offering (GlobeNewswire)

Zhengye Biotechnology Holding Ltd. engages in the manufacture and sale of veterinary vaccines. It offers a range of vaccines, including vaccines for swine, cattle, goats, sheep, poultry, and dogs. The company was founded on March 24, 2023 and is headquartered in Jilin City, China.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Zhengye Biotechnology Holding Ltd

Upgrade your FINVIZ experience